CAR-T “the living drugs”, immune checkpoint inhibitors, and precision medicine: a new era of cancer therapy

New advances in the design and manufacture of monoclonal antibodies, bispecific T cell engagers, and antibody-drug conjugates make the antibody-directed agents more powerful with less toxicities. Small molecul...
Source: Journal of Hematology and Oncology - Category: Hematology Authors: Tags: Editorial Source Type: research